We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.83% | 27.75 | 27.50 | 28.00 | 27.75 | 27.25 | 27.25 | 1,058,943 | 14:49:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 11.65 | 185.4M |
TIDMHVO
RNS Number : 4951J
hVIVO plc
18 December 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or the underlying hVIVO plc issuer of existing shares to which voting rights are attached: (ii) --------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes -------------------------------------------------------------------------------- -------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------- -------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------- -------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------- -------- Other (please specify): ------------------ ------------------------------------------------------------ -------- 3. Full name of person(s) subject Ruffer LLP (for its discretionary clients to the of the Ruffer Group) notification obligation: (iii) ---------------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ---------------------------------------------- 5. Date of the transaction and date 16 December 2015 on which the threshold is crossed or reached: (v) ---------------------------------------------- 6. Date on which issuer notified: 17 December 2015 ---------------------------------------------- 7. Threshold(s) that is/are crossed 5% to less than 5% or reached: (vi, vii) ---------------------------------------------- 8. Notified details: A: Voting rights attached to shares (viii, ix) Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------------------------- ----------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ------------ ------------------ ---------- ----------------------- ---------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) --- ------- ------ ----- --- ---------- ------------ --------- -------------- ------------ - Less than - 5% GB00B6ZM0X53 ------ ---------- --- --------- -------------- ------------ 3,621,538 3,621,538 3,828,538 3,828,538 ------------ ------------------ ---------- ------------ --------- --- --- ---- ----------- B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. --------------- --------------------------- ---------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ------------ ------------- --------------- ---------------------------- ----------------------- Nominal Delta ------------ ------------- --------------- ---------------------------- ---------- ----------- Total (A+B+C) Number of voting rights Percentage of voting rights ----------------------------------------------------- 3,828,538 Less than 5% ----------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) N/A Proxy Voting: 10. Name of the proxy holder: N/A --------------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------- Ruffer LLP controls the voting rights 13. Additional information: over 3,828,538 shares (now less than 5% of the voting rights) of hVIVO plc which are held by the discretionary clients of Ruffer LLP and its subsidiaries (the voting of which is all controlled by Ruffer LLP). This change from 5% to less than 5% is due to a recent placing of 9,111,111 new Ordinary Shares in which Ruffer LLP purchased 207,000 shares. The new shares were admitted to the market on 16 December 2015. The total number of voting rights in hVIVO plc is now 78,052,784. 14. Contact name: Louise Stanway ---------------------------------------------- 15. Contact telephone number: 020 7963 8146 ----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEANAXFENSFFF
(END) Dow Jones Newswires
December 18, 2015 02:00 ET (07:00 GMT)
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions